Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06181994 · ClinicalTrials.gov registry record

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

A clinical trial of Chronic Subdural Hematoma, sponsored by Montefiore Medical Center.

Recruiting
Registry status
5,000
Enrollment target
19
Study locations

NCT06181994 is a study of Chronic Subdural Hematoma that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5,000 participants, above the 192-participant average among 4 other Chronic Subdural Hematoma trials with a reported enrollment target (2504% higher). The trial reports 19 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06181994, a study of Chronic Subdural Hematoma, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
5,000 participants
Enrollment target
19
Study locations

Study Summary

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Conditions Studied

Chronic Subdural Hematoma

Study Locations (19)

Florida

  • Baptist Health South Florida, Inc. - Coral Gables
  • Mayo Clinic Florida - Jacksonville
  • Orlando Regional Medical Center - Orlando

Massachusetts

  • Massachusetts General Hospital - Boston
  • Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School - Boston
  • Lahey Hospital and Medical Center - Burlington

Ontario

  • Unity Health Toronto - Toronto
  • University of Toronto - Toronto
  • Toronto Western Hospital - Toronto

Illinois

  • University of Illinois Chicago - Chicago
  • University of Chicago Medicine - Chicago

Pennsylvania

  • Geisinger Health - Danville
  • Thomas Jefferson University - Philadelphia

Texas

  • UTHealth Houston - Houston
  • HCA Houston Healthcare Kingwood - Kingwood

Iowa

  • The University of Iowa - Iowa City

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2023-12-05
Est. Completion 2026-08

Sponsor

Montefiore Medical Center

345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06181994

The ClinicalTrials.gov registry entry for NCT06181994 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 192-participant average among 4 other Chronic Subdural Hematoma trials with a reported enrollment target (2504% higher). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Subdural Hematoma appearing as the primary indexed condition, and to 0 interventions.

NCT06181994 reports 19 study locations spanning 10 distinct geographic areas - top geographies include Florida, Massachusetts, Ontario.

Frequently Asked Questions

What is clinical trial NCT06181994 about?

NCT06181994 is a clinical study titled "Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)". This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

What is the current status of trial NCT06181994?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-12-05. Estimated completion is 2026-08.

What conditions does trial NCT06181994 study?

This clinical trial studies the following conditions: Chronic Subdural Hematoma.

Who is sponsoring clinical trial NCT06181994?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06181994 being conducted?

This trial has 19 study locations across Florida, Illinois, Iowa, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Subdural Hematoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Subdural Hematoma

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.